In a move to expand its ophthalmic platform, Sandoz, the former generics and biosimilars arm of Swiss drugmaker Novartis, has completed the acquisition of Coherus...
13.12.2017
- From Jan. 1, 2018, Bayer will streamline its strategic pharmaceutical research and development activities and combine them under a single unit covering the therapeutic areas...
19.05.2016
- Swiss drugmaker Novartis has announced plans to split its Pharmaceutical division into two business units, Novartis Pharmaceutical and Novartis Oncology. The first-mentioned will...
